Table 4 Association between VAI and fasting plasma glucose, stratified by age, gender, diabetes, hypertension and hyperlipidemia
Exposure | N | β (95%CI) | P value | P for interaction |
|---|---|---|---|---|
Stratified by age | 0.47 (0.34, 0.60) | 0.0019 | ||
< 60 | 3094 | 0.58 (0.36, 0.80) | < 0.0001 | |
≥ 60 | 1343 | < 0.0001 | ||
Stratified by gender | 0.1066 | |||
Male | 2175 | 0.63 (0.45, 0.82) | < 0.0001 | |
Female | 2262 | 0.55 (0.41–0.63) | < 0.0001 | |
Stratified by diabetes | < 0.0001 | |||
Non-diabetes | 3835 | 0.34 (0.27, 0.41) | < 0.0001 | |
Diabetes | 602 | 0.59 (0.41–1.19) | 0.0535 | |
Stratified by antidiabetic treatment | 0.0826 | |||
Receiving antidiabetic treatment | 500 | 0.61 (−0.31,1.52) | 0.1953 | |
Not receiving antidiabetic treatment | 102 | −0.17 (−2.64, 2.31) | 0.8948 | |
Stratified by hypertension | < 0.0001 | |||
Non-hypertension | 2983 | 0.29 (0.18, 0.40) | < 0.0001 | |
Hypertension | 1454 | 0.93 (0.68, 1.17) | < 0.0001 | |
Stratified by lipidemia | 0.0012 | |||
Non-lipidemia | 3058 | 0.31 (0.18, 0.44) | < 0.0001 | |
Lipidemia | 1379 | 0.80 (0.60, 1.01) | < 0.0001 |